Ganciclovir treatment of cytomegalovirus disease in transplant recipients and other immunocompromised hosts
- 12 June 1987
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA
- Vol. 257 (22) , 3082-3087
- https://doi.org/10.1001/jama.257.22.3082
Abstract
Research from JAMA — Ganciclovir Treatment of Cytomegalovirus Disease in Transplant Recipients and Other Immunocompromised HostsThis publication has 25 references indexed in Scilit:
- Rapid Immunodiagnosis of Cytomegalovirus Pneumonia by Bronchoalveolar Lavage Using Human and Murine Monoclonal AntibodiesAnnals of Internal Medicine, 1986
- Effect of 9-(1,3-Dihydroxy-2-Propoxymethyl) Guanine on Serious Cytomegalovirus Disease in Eight Immunosuppressed Homosexual MenAnnals of Internal Medicine, 1986
- 9-(1,3-dihydroxy-2-propoxymethyl)guanine for Cytomegalovirus Infections in Patients with the Acquired Immunodeficiency SyndromeAnnals of Internal Medicine, 1985
- Treatment of Cytomegalovirus Retinitis with 9-[2-Hydroxy-1-(hydroxymethyl)ethoxymethyl]guanineAnnals of Internal Medicine, 1985
- Activity of 9-[2-Hydroxy-1-(hydroxymethyl)ethoxymethyl]guanine in the Treatment of Cytomegalovirus PneumoniaAnnals of Internal Medicine, 1985
- The Acquired Immunodeficiency Syndrome: An UpdateAnnals of Internal Medicine, 1985
- Bronchoalveolar Lavage in the Diagnosis of Diffuse Pulmonary Infiltrates in the Immunosuppressed HostAnnals of Internal Medicine, 1984
- Cytomegalovirus Retinitis in Immunosuppressed HostsAnnals of Internal Medicine, 1980
- Cytomegalovirus Disease in Renal Allograft RecipientsMedicine, 1980
- Toxicity and Efficacy of Human Leukocyte Interferon for Treatment of Cytomegalovirus Pneumonia after Marrow TransplantationThe Journal of Infectious Diseases, 1980